The Role of the CMO in BD and M&A Partnering with Pharma

In this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can support the conversations and operations that take place throughout the process of business development. Specifically:Different kinds of BD deals to be aware ofHow the CMO fits into various phases of transactionsAppreciating how different c-suite colleagues and direct reports experience these transactionsThe different pharma teams CMOs will interact withWhat happens after the acquisitionTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.